FDA applicant
LimFlow, Inc.
FDA records 7 decisions for LimFlow, Inc. (San Jose, CA) from 2022 to 2026: 6 510(k) clearances and 1 original PMA approval. Most are in product codes MGZ (Valvulotome) and MMX (Device, Percutaneous Retrieval). Since 2016 its 510(k)s took a median of 29 days from receipt to decision, against 139 for FDA’s reviews in the same codes and years. Its devices cite 6 predicates, 3 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided LimFlow, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2025
2026 so far, outlined.
Recalls per year
1in 2025
Class I Class II/III not classified
Planning a device like LimFlow, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report